Global Veterinary Viral Vectored Vaccine Market Research Report 2024

Report ID: 1858335 | Published Date: Jan 2025 | No. of Page: 73 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Veterinary Viral Vectored Vaccine Market Overview
    1.1 Product Overview and Scope of Veterinary Viral Vectored Vaccine
    1.2 Veterinary Viral Vectored Vaccine Segment by Type
        1.2.1 Global Veterinary Viral Vectored Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Alphaherpesvirus (HVT) Vector
        1.2.3 Canarypox Vector
        1.2.4 Vaccinia Vector
    1.3 Veterinary Viral Vectored Vaccine Segment by Application
        1.3.1 Global Veterinary Viral Vectored Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 Pet
        1.3.3 Chicken
        1.3.4 Others
    1.4 Global Veterinary Viral Vectored Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Veterinary Viral Vectored Vaccine Revenue 2017-2028
        1.4.2 Global Veterinary Viral Vectored Vaccine Sales 2017-2028
        1.4.3 Veterinary Viral Vectored Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Veterinary Viral Vectored Vaccine Market Competition by Manufacturers
    2.1 Global Veterinary Viral Vectored Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Veterinary Viral Vectored Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Veterinary Viral Vectored Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Veterinary Viral Vectored Vaccine Market Competitive Situation and Trends
        2.5.1 Veterinary Viral Vectored Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Veterinary Viral Vectored Vaccine Players Market Share by Revenue
        2.5.3 Global Veterinary Viral Vectored Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Viral Vectored Vaccine Retrospective Market Scenario by Region
    3.1 Global Veterinary Viral Vectored Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Veterinary Viral Vectored Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
        3.3.1 North America Veterinary Viral Vectored Vaccine Sales by Country
        3.3.2 North America Veterinary Viral Vectored Vaccine Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
        3.4.1 Europe Veterinary Viral Vectored Vaccine Sales by Country
        3.4.2 Europe Veterinary Viral Vectored Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Veterinary Viral Vectored Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Veterinary Viral Vectored Vaccine Sales by Region
        3.5.2 Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Veterinary Viral Vectored Vaccine Sales by Country
        3.6.2 Latin America Veterinary Viral Vectored Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Veterinary Viral Vectored Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Veterinary Viral Vectored Vaccine Sales by Country
        3.7.2 Middle East and Africa Veterinary Viral Vectored Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Veterinary Viral Vectored Vaccine Historic Market Analysis by Type
    4.1 Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Veterinary Viral Vectored Vaccine Price by Type (2017-2022)
5 Global Veterinary Viral Vectored Vaccine Historic Market Analysis by Application
    5.1 Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Veterinary Viral Vectored Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Veterinary Viral Vectored Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Boehringer-Ingelheim
        6.1.1 Boehringer-Ingelheim Corporation Information
        6.1.2 Boehringer-Ingelheim Description and Business Overview
        6.1.3 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product Portfolio
        6.1.5 Boehringer-Ingelheim Recent Developments/Updates
    6.2 Ceva
        6.2.1 Ceva Corporation Information
        6.2.2 Ceva Description and Business Overview
        6.2.3 Ceva Veterinary Viral Vectored Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Ceva Veterinary Viral Vectored Vaccine Product Portfolio
        6.2.5 Ceva Recent Developments/Updates
7 Veterinary Viral Vectored Vaccine Manufacturing Cost Analysis
    7.1 Veterinary Viral Vectored Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Veterinary Viral Vectored Vaccine
    7.4 Veterinary Viral Vectored Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Veterinary Viral Vectored Vaccine Distributors List
    8.3 Veterinary Viral Vectored Vaccine Customers
9 Veterinary Viral Vectored Vaccine Market Dynamics
    9.1 Veterinary Viral Vectored Vaccine Industry Trends
    9.2 Veterinary Viral Vectored Vaccine Market Drivers
    9.3 Veterinary Viral Vectored Vaccine Market Challenges
    9.4 Veterinary Viral Vectored Vaccine Market Restraints
10 Global Market Forecast
    10.1 Veterinary Viral Vectored Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Veterinary Viral Vectored Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Veterinary Viral Vectored Vaccine by Type (2023-2028)
    10.2 Veterinary Viral Vectored Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Veterinary Viral Vectored Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Veterinary Viral Vectored Vaccine by Application (2023-2028)
    10.3 Veterinary Viral Vectored Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Veterinary Viral Vectored Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Veterinary Viral Vectored Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Veterinary Viral Vectored Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
    Table 2. Global Veterinary Viral Vectored Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
    Table 3. Global Veterinary Viral Vectored Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Veterinary Viral Vectored Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Veterinary Viral Vectored Vaccine Sales (Units) of Key Manufacturers (2017-2022)
    Table 6. Global Veterinary Viral Vectored Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Veterinary Viral Vectored Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Veterinary Viral Vectored Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Veterinary Viral Vectored Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Veterinary Viral Vectored Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Veterinary Viral Vectored Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Veterinary Viral Vectored Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Viral Vectored Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Veterinary Viral Vectored Vaccine Sales by Region (2017-2022) & (Units)
    Table 16. Global Veterinary Viral Vectored Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Veterinary Viral Vectored Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Veterinary Viral Vectored Vaccine Sales by Country (2017-2022) & (Units)
    Table 20. North America Veterinary Viral Vectored Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Veterinary Viral Vectored Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Veterinary Viral Vectored Vaccine Sales by Country (2017-2022) & (Units)
    Table 24. Europe Veterinary Viral Vectored Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Veterinary Viral Vectored Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Veterinary Viral Vectored Vaccine Sales by Region (2017-2022) & (Units)
    Table 28. Asia Pacific Veterinary Viral Vectored Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Veterinary Viral Vectored Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Veterinary Viral Vectored Vaccine Sales by Country (2017-2022) & (Units)
    Table 32. Latin America Veterinary Viral Vectored Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Veterinary Viral Vectored Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Veterinary Viral Vectored Vaccine Sales by Country (2017-2022) & (Units)
    Table 36. Middle East and Africa Veterinary Viral Vectored Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Veterinary Viral Vectored Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Veterinary Viral Vectored Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Veterinary Viral Vectored Vaccine Sales by Type (2017-2022) & (Units)
    Table 40. Global Veterinary Viral Vectored Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Veterinary Viral Vectored Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Veterinary Viral Vectored Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Veterinary Viral Vectored Vaccine Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Veterinary Viral Vectored Vaccine Sales (Units) by Application (2017-2022)
    Table 45. Global Veterinary Viral Vectored Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Veterinary Viral Vectored Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Veterinary Viral Vectored Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Veterinary Viral Vectored Vaccine Price by Application (2017-2022) & (US$/Unit)
    Table 49. Boehringer-Ingelheim Corporation Information
    Table 50. Boehringer-Ingelheim Description and Business Overview
    Table 51. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product
    Table 53. Boehringer-Ingelheim Recent Developments/Updates
    Table 54. Ceva Corporation Information
    Table 55. Ceva Description and Business Overview
    Table 56. Ceva Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Ceva Veterinary Viral Vectored Vaccine Product
    Table 58. Ceva Recent Developments/Updates
    Table 59. Production Base and Market Concentration Rate of Raw Material
    Table 60. Key Suppliers of Raw Materials
    Table 61. Veterinary Viral Vectored Vaccine Distributors List
    Table 62. Veterinary Viral Vectored Vaccine Customers List
    Table 63. Veterinary Viral Vectored Vaccine Market Trends
    Table 64. Veterinary Viral Vectored Vaccine Market Drivers
    Table 65. Veterinary Viral Vectored Vaccine Market Challenges
    Table 66. Veterinary Viral Vectored Vaccine Market Restraints
    Table 67. Global Veterinary Viral Vectored Vaccine Sales Forecast by Type (2023-2028) & (Units)
    Table 68. Global Veterinary Viral Vectored Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 69. Global Veterinary Viral Vectored Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 70. Global Veterinary Viral Vectored Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 71. Global Veterinary Viral Vectored Vaccine Sales Forecast by Application (2023-2028) & (Units)
    Table 72. Global Veterinary Viral Vectored Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 73. Global Veterinary Viral Vectored Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 74. Global Veterinary Viral Vectored Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 75. Global Veterinary Viral Vectored Vaccine Sales Forecast by Region (2023-2028) & (Units)
    Table 76. Global Veterinary Viral Vectored Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 77. Global Veterinary Viral Vectored Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 78. Global Veterinary Viral Vectored Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Veterinary Viral Vectored Vaccine
    Figure 2. Global Veterinary Viral Vectored Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Alphaherpesvirus (HVT) Vector Product Picture
    Figure 4. Canarypox Vector Product Picture
    Figure 5. Vaccinia Vector Product Picture
    Figure 6. Global Veterinary Viral Vectored Vaccine Market Share by Application in 2021 & 2028
    Figure 7. Pet
    Figure 8. Chicken
    Figure 9. Others
    Figure 10. Global Veterinary Viral Vectored Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Veterinary Viral Vectored Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Veterinary Viral Vectored Vaccine Sales (2017-2028) & (Units)
    Figure 13. Veterinary Viral Vectored Vaccine Sales Share by Manufacturers in 2021
    Figure 14. Global Veterinary Viral Vectored Vaccine Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Veterinary Viral Vectored Vaccine Players: Market Share by Revenue in 2021
    Figure 16. Veterinary Viral Vectored Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Veterinary Viral Vectored Vaccine Sales Market Share by Region (2017-2022)
    Figure 18. Global Veterinary Viral Vectored Vaccine Sales Market Share by Region in 2021
    Figure 19. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Region (2017-2022)
    Figure 20. Global Veterinary Viral Vectored Vaccine Revenue Market Share by Region in 2021
    Figure 21. United States Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Taiwan Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Colombia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Veterinary Viral Vectored Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Veterinary Viral Vectored Vaccine by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Veterinary Viral Vectored Vaccine
    Figure 46. Manufacturing Process Analysis of Veterinary Viral Vectored Vaccine
    Figure 47. Veterinary Viral Vectored Vaccine Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer-Ingelheim
Ceva
Frequently Asked Questions
Veterinary Viral Vectored Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Veterinary Viral Vectored Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Veterinary Viral Vectored Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bicycle Pannier

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More